Condition
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma clinical trials and research
Research outlook What's coming for Stomach cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Gastric Cancer or Gastroesophageal Junction Adenocarcinoma clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Oral Paclitaxel Plus Fruquintinib as Second-Line Treatment in Advanced Gastric/GEJ Cancer
This trial tests whether taking an oral paclitaxel solution together with fruquintinib, chosen by the investigator, can help adults with advanced or metastatic stomach or gastroesophageal junction cancer after first-line therapy.
-
Sintilimab plus SOX chemotherapy versus SOX alone after surgery for stomach or gastroesophageal junction adenocarcinoma
This trial will test whether adding sintilimab to SOX chemotherapy after surgery helps people with stage IIIC or dMMR/MSI‑H stage IIIA/IIIB stomach or gastroesophageal junction cancer stay disease‑free longer.
Related topics
Quick answers
How many Gastric Cancer or Gastroesophageal Junction Adenocarcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.